Skip to content

Clinical trials

Withdrawn Carcinoma, Ovarian Epithelial trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Status: Withdrawn Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20052
20083
20101
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Alabama at Birmingham2
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Fox Chase Cancer Center1
Genzyme, a Sanofi Company1
George Washington University1
M.D. Anderson Cancer Center1
Mayo Clinic1
OHSU Knight Cancer Institute1
University of Chicago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial12
Ovarian Neoplasms9
Fallopian Tube Neoplasms2
Blast Crisis1
Breast Neoplasms1
Burkitt Lymphoma1
Congenital Abnormalities1
Dendritic Cell Sarcoma, Interdigitating1
Endometrial Neoplasms1
Hodgkin Disease1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.